SCHIZOPHRENIA: A COMPREHENSIVE GUIDE

(Note: For PDF File Swipe To The End Of Article)

1. INTRODUCTION

Schizophrenia is one of the most important and complex psychiatric disorders encountered in clinical medicine. It is a serious mental health condition that affects how an individual thinks, perceives reality, experiences emotions, communicates, and behaves. The disorder can significantly interfere with education, employment, relationships, social activities, and independent living.

A person with schizophrenia may experience hallucinations, delusions, disorganized thinking, unusual behaviour, reduced emotional expression, and difficulties with memory and concentration. These symptoms can make ordinary daily activities challenging.

Schizophrenia is not simply a condition in which a person behaves strangely or has unusual thoughts. It is a recognized psychiatric disorder involving disturbances in several interconnected brain functions.

The illness usually begins during late adolescence or early adulthood, although it can develop at other ages. Its course varies considerably. Some individuals experience a single episode followed by substantial recovery, while others experience repeated episodes or persistent symptoms requiring long-term treatment.

An important fact about schizophrenia is that it is treatable. Antipsychotic medications, psychological therapies, family interventions, rehabilitation, and community-based support can significantly improve symptoms and quality of life.

Although schizophrenia can be a long-term condition, it does not mean that a person cannot study, work, maintain relationships, or achieve personal goals. With appropriate treatment and support, many individuals can lead meaningful and productive lives.

2. DEFINITION OF SCHIZOPHRENIA

Schizophrenia is a chronic or episodic psychiatric disorder characterized by disturbances in thought processes, perception, emotional expression, behaviour, and social functioning.

It is commonly associated with psychotic symptoms, including:

• Delusions.
• Hallucinations.
• Disorganized speech.
• Disorganized or abnormal motor behaviour.
• Negative symptoms.
• Cognitive impairment.

Psychosis refers to a condition in which a person's perception or interpretation of reality becomes significantly disturbed.

Schizophrenia is one of the major disorders associated with psychosis, but not every person experiencing psychosis has schizophrenia.

The diagnosis requires a comprehensive psychiatric assessment, including the duration and pattern of symptoms, functional impairment, and exclusion of alternative causes.

3. EPIDEMIOLOGY

Schizophrenia occurs throughout the world and affects people from different socioeconomic, cultural, educational, and geographical backgrounds.

3.1 Global prevalence

According to the World Health Organization, approximately 27 million people worldwide live with schizophrenia, corresponding to approximately 1 in 300 people.

The disorder is relatively less common than depression and anxiety disorders, but its effects on individuals, families, healthcare systems, and society can be substantial.

3.2 Age of onset

Schizophrenia most commonly develops during late adolescence and early adulthood.

The usual pattern includes:

• Earlier onset in males than females on average.
• First symptoms frequently appearing during adolescence or the twenties.
• Many diagnoses occurring between approximately 16 and 30 years of age.
• Childhood-onset schizophrenia being uncommon.
• New onset in later adulthood being less common and requiring careful evaluation for other causes.

3.3 Gender distribution

Schizophrenia affects both males and females.

Some differences are observed in the average age of onset and clinical course. Males tend to develop symptoms earlier, while females may experience a later onset.

The illness should never be considered exclusively a disease of one gender.

3.4 Geographical distribution

Schizophrenia occurs in both developed and developing countries.

Its occurrence is influenced by multiple biological, environmental, social, and developmental factors.

3.5 Socioeconomic factors

People living with schizophrenia may experience difficulties related to:

• Poverty.
• Unemployment.
• Social isolation.
• Limited access to psychiatric services.
• Housing insecurity.
• Educational difficulties.
• Discrimination and stigma.

These factors may increase the burden of illness and make treatment more difficult.

4. CAUSES AND ETIOLOGY

There is no single established cause of schizophrenia.

Current scientific understanding suggests that schizophrenia develops through an interaction between genetic susceptibility, brain development, neurochemical processes, environmental exposures, and psychosocial influences.

4.1 Genetic factors

Genetic susceptibility plays an important role in schizophrenia.

The disorder tends to occur more frequently among individuals who have close biological relatives with the condition.

However, schizophrenia is not inherited through one simple gene. Many genetic variations may contribute to an individual's susceptibility.

Important observations include:

• Having a first-degree relative with schizophrenia increases risk.
• The risk is higher in identical twins than in the general population.
• Not everyone with a genetic predisposition develops schizophrenia.
• Environmental factors may influence whether the illness develops.

Genetic susceptibility should not be interpreted as certainty that a person will develop the disorder.

4.2 Neurochemical abnormalities

Brain cells communicate through chemical messengers known as neurotransmitters.

Abnormalities in neurotransmitter activity are believed to contribute to some symptoms of schizophrenia.

A. Dopamine hypothesis

Dopamine is a neurotransmitter involved in motivation, reward, movement, attention, and emotional responses.

The dopamine hypothesis suggests that abnormal dopamine signalling contributes to schizophrenia.

Important concepts include:

• Increased dopamine activity in certain mesolimbic pathways may contribute to positive symptoms.
• Reduced dopamine activity in certain prefrontal pathways may contribute to some negative and cognitive symptoms.
• Dopamine receptor activity is an important target of many antipsychotic medications.

This hypothesis is useful for understanding treatment, although schizophrenia cannot be explained by dopamine alone.

B. Glutamate hypothesis

Glutamate is the major excitatory neurotransmitter in the central nervous system.

Abnormalities involving glutamate signalling, particularly NMDA receptor function, have been investigated in schizophrenia.

These abnormalities may contribute to:

• Cognitive difficulties.
• Disturbed perception.
• Negative symptoms.
• Abnormal communication between brain regions.

C. Serotonin abnormalities

Serotonin participates in mood regulation, sleep, cognition, and perception.

Serotonergic pathways are involved in the action of several atypical antipsychotic medications.

Abnormal serotonin signalling may contribute to some clinical features of schizophrenia.

4.3 Brain structure and functional abnormalities

Research has identified differences in brain structure and activity in some individuals with schizophrenia.

These findings are not sufficiently specific to diagnose schizophrenia in an individual patient.

Areas studied include:

• Prefrontal cortex.
• Hippocampus.
• Temporal lobes.
• Thalamus.
• Limbic structures.
• Brain networks involved in attention and executive functioning.

Some studies have demonstrated changes in grey matter volume, connectivity, and brain activity.

These findings help researchers understand the disorder but do not provide a single diagnostic brain scan.

4.4 Prenatal and perinatal factors

Certain complications during pregnancy and childbirth have been associated with an increased risk of schizophrenia.

Possible factors include:

• Maternal infections during pregnancy.
• Maternal malnutrition.
• Severe prenatal stress.
• Pregnancy complications.
• Premature birth.
• Low birth weight.
• Complications associated with reduced oxygen supply.

These factors are associated with risk and do not mean that every exposed child will develop schizophrenia.

4.5 Environmental factors

Environmental influences may interact with genetic susceptibility.

Possible contributors include:

• Childhood adversity.
• Exposure to chronic stress.
• Social isolation.
• Urban upbringing.
• Migration-related stress.
• Poverty.
• Traumatic experiences.
• Certain infectious and developmental exposures.

The relationship between these factors and schizophrenia is complex.

4.6 Substance use

Some substances can increase the risk of psychotic experiences or worsen existing psychotic disorders.

Important examples include:

Cannabis: Heavy or frequent cannabis use, particularly products containing high concentrations of THC, is associated with an increased risk of psychosis.

Amphetamines: Stimulants may cause severe agitation, paranoia, hallucinations, and delusions.

Cocaine: Cocaine can produce substance-induced psychosis, particularly with heavy use.

Hallucinogens: Certain hallucinogenic substances may cause perceptual disturbances and psychotic symptoms.

Alcohol: Alcohol intoxication and withdrawal can produce psychiatric and neurological complications that may resemble psychosis.

Substance use does not automatically establish a diagnosis of schizophrenia. A clinician must assess the timing of symptoms in relation to substance exposure.

5. RISK FACTORS

Risk factors are characteristics or exposures that increase the likelihood of developing schizophrenia.

Important risk factors include:

1. Family history of schizophrenia.
2. Genetic susceptibility.
3. Prenatal infections.
4. Pregnancy complications.
5. Early developmental disturbances.
6. Childhood adversity.
7. Severe or prolonged psychological stress.
8. Heavy cannabis use.
9. Exposure to certain psychoactive substances.
10. Social disadvantage.
11. Urban environmental exposures.
12. Certain neurological and developmental abnormalities.

Important: Having one or more risk factors does not mean that a person will definitely develop schizophrenia.

6. PATHOPHYSIOLOGY

The pathophysiology of schizophrenia involves complex disturbances in brain development, neurotransmission, neural connectivity, information processing, and cognitive functioning.

The exact mechanisms remain under investigation.

6.1 Abnormal dopamine signalling

Dopamine dysregulation is one of the most established neurochemical models of schizophrenia.

Increased dopamine synthesis and release in certain brain pathways may contribute to abnormal assignment of importance to ordinary experiences.

For example, an individual may interpret an ordinary sound, conversation, or environmental event as having a special personal meaning.

This may contribute to the development of delusions and other positive symptoms.

6.2 Prefrontal cortical dysfunction

The prefrontal cortex plays an important role in:

• Planning.
• Decision-making.
• Attention.
• Working memory.
• Emotional regulation.
• Problem-solving.
• Social behaviour.

Abnormalities in prefrontal networks may contribute to reduced motivation, poor concentration, impaired judgment, and difficulties organizing daily activities.

6.3 Hippocampal dysfunction

The hippocampus is involved in memory formation, learning, and contextual processing.

Abnormalities in hippocampal activity may contribute to disturbances in memory and the interpretation of experiences.

6.4 Neural connectivity abnormalities

Different regions of the brain communicate through interconnected networks.

Schizophrenia may involve disturbances in the coordination of these networks.

Such disturbances may contribute to:

• Disorganized thinking.
• Reduced cognitive efficiency.
• Abnormal sensory processing.
• Difficulties integrating information.

6.5 Neurodevelopmental theory

The neurodevelopmental theory suggests that schizophrenia may originate from disturbances in brain development occurring before birth or during early life.

These disturbances may remain relatively subtle for years.

During adolescence and early adulthood, changes in brain maturation and environmental stress may contribute to the emergence of symptoms in susceptible individuals.

7. CLASSIFICATION OF SCHIZOPHRENIA

Schizophrenia has historically been divided into several clinical subtypes.

Older classifications included paranoid, disorganized, catatonic, undifferentiated, and residual schizophrenia.

These subtypes are no longer used as formal diagnostic subtypes in DSM-5-TR because they were not sufficiently stable or clinically useful.

Nevertheless, understanding these historical terms can help students recognize older textbooks and examination questions.

7.1 Paranoid type

Historically, this subtype was characterized mainly by prominent delusions and hallucinations.

Common features included:

• Persecutory delusions.
• Grandiose delusions.
• Auditory hallucinations.
• Suspiciousness.
• Relatively organized speech compared with some other presentations.

7.2 Disorganized type

This historical subtype involved prominent disturbances in speech, behaviour, and emotional expression.

Features included:

• Disorganized speech.
• Inappropriate emotional responses.
• Difficulty performing daily activities.
• Disorganized behaviour.
• Reduced ability to maintain personal care.

7.3 Catatonic type

This historical subtype involved marked abnormalities of movement and responsiveness.

Features could include:

• Stupor.
• Mutism.
• Negativism.
• Posturing.
• Rigidity.
• Waxy flexibility.
• Repetitive movements.
• Unusual motor activity.

Catatonia is now recognized as a syndrome that can occur in several psychiatric and medical conditions, not only schizophrenia.

7.4 Undifferentiated type

This historical category was used when patients demonstrated important features of schizophrenia without fitting clearly into one specific subtype.

7.5 Residual type

This historical term described individuals who had previously experienced prominent psychotic symptoms but currently showed fewer positive symptoms, with persistent negative or residual symptoms.

7.6 Modern clinical description

Modern assessment focuses on the actual symptoms, their severity, duration, functional effects, and course.

Clinicians describe whether the person has:

• Predominantly positive symptoms.
• Predominantly negative symptoms.
• Significant cognitive impairment.
• Catatonic features.
• Recurrent episodes.
• Partial or complete remission.
• Persistent symptoms.

8. SIGNS AND SYMPTOMS OF SCHIZOPHRENIA

The clinical presentation of schizophrenia varies between individuals.

Symptoms are commonly divided into positive symptoms, negative symptoms, cognitive symptoms, and mood-related symptoms.

8.1 Positive symptoms

Positive symptoms refer to experiences or behaviours that are added to normal functioning.

They include hallucinations, delusions, disorganized speech, and abnormal behaviour.

A. Delusions

A delusion is a fixed false belief that is maintained despite clear evidence against it and is not adequately explained by the person's cultural or religious background.

Common types include:

Persecutory delusions: The person believes that others are trying to harm, monitor, threaten, or persecute them.

Example: A patient believes that neighbours have installed hidden cameras to monitor their activities.

Grandiose delusions: The person believes that they possess exceptional abilities, power, wealth, or importance.

Example: A patient believes that they are a famous world leader despite having no evidence supporting this belief.

Delusions of reference: The person believes that ordinary events, television programmes, conversations, or gestures contain special messages directed specifically at them.

Somatic delusions: The person has a fixed false belief concerning their body or physical condition.

Thought broadcasting: The person believes that their thoughts are being transmitted or made accessible to other people.

Thought insertion: The person experiences thoughts as being placed into their mind by an external source.

Thought withdrawal: The person believes that thoughts are being removed from their mind by another person or force.

Delusions of control: The person believes that their actions, feelings, or movements are controlled by an external force.

B. Hallucinations

A hallucination is a sensory experience that occurs without an external stimulus corresponding to that experience.

Hallucinations may involve different sensory modalities.

Auditory hallucinations:

These are among the most common hallucinations in schizophrenia.

Patients may report:

• Hearing voices.
• Hearing people talking when nobody is present.
• Hearing voices commenting on their activities.
• Hearing two or more voices discussing them.
• Hearing threatening or insulting voices.

Visual hallucinations:

Patients may see people, objects, animals, lights, or other images that are not actually present.

Prominent visual hallucinations should also prompt evaluation for medical, neurological, substance-related, or other psychiatric causes.

Olfactory hallucinations:

The patient may smell odours that are not present.

Gustatory hallucinations:

The patient experiences tastes without an external source.

Tactile hallucinations:

The patient experiences sensations such as insects crawling on the skin or someone touching the body when no such stimulus exists.

C. Disorganized speech

Disorganized speech reflects disturbances in the organization and flow of thoughts.

Examples include:

• Frequently changing topics without a clear connection.
• Giving irrelevant answers.
• Producing speech that is difficult to understand.
• Combining unrelated ideas.
• Using unusual words.
• Losing the main point of a conversation.

Some clinical terms include:

Derailment: The patient shifts from one topic to another with weak or absent connections.

Tangentiality: The patient moves away from the original question and does not provide a direct answer.

Neologisms: The patient creates new words or expressions that are not understood by others.

Word salad: Speech becomes severely disorganized, with words or phrases lacking understandable connections.

Circumstantiality: The patient provides excessive unnecessary details but eventually returns to the main point.

D. Disorganized behaviour

Behaviour may become unpredictable, inappropriate, or difficult to organize.

Examples include:

• Wearing inappropriate clothing for the weather.
• Performing activities without an understandable purpose.
• Neglecting personal hygiene.
• Difficulty following daily routines.
• Inappropriate social behaviour.
• Sudden unusual actions.

8.2 Negative symptoms

Negative symptoms involve a reduction or loss of normal emotional, motivational, and behavioural functions.

They may be particularly disabling because they interfere with daily activities and social relationships.

Important negative symptoms include:

A. Affective flattening

The patient shows reduced emotional expression.

Facial expressions, voice tone, and gestures may become limited.

B. Alogia

Alogia refers to reduced speech output.

The patient may provide very short answers and speak less than expected.

C. Avolition

Avolition is a reduction in motivation and the ability to initiate and continue goal-directed activities.

The person may struggle to:

• Take a bath.
• Prepare meals.
• Attend classes.
• Complete household work.
• Maintain employment.
• Follow daily routines.

D. Anhedonia

Anhedonia refers to a reduced ability to experience pleasure from activities that were previously enjoyable.

E. Asociality

Asociality involves reduced interest in social interactions and relationships.

The person may spend increasing amounts of time alone and withdraw from family or friends.

Negative symptoms should be carefully distinguished from depression, medication side effects, substance use, and social deprivation.

8.3 Cognitive symptoms

Cognitive impairment is common in schizophrenia.

It may affect the person's ability to learn, remember information, concentrate, and make decisions.

Important cognitive symptoms include:

• Poor attention.
• Reduced concentration.
• Impaired working memory.
• Difficulty processing information.
• Reduced problem-solving ability.
• Poor planning.
• Difficulty organizing tasks.
• Impaired executive functioning.

For example, a student with schizophrenia may understand a lesson but have difficulty remembering its details or organizing information during an examination.

8.4 Mood-related symptoms

Some individuals experience depression, anxiety, irritability, or mood disturbances.

Possible symptoms include:

• Persistent sadness.
• Loss of interest.
• Hopelessness.
• Anxiety.
• Sleep disturbances.
• Reduced appetite.
• Suicidal thoughts.

Mood symptoms may occur during acute psychosis or at other stages of the illness.

9. EARLY WARNING SIGNS

Schizophrenia may develop gradually.

Before the first major psychotic episode, some individuals experience a period of subtle changes known as the prodromal phase.

Possible early warning signs include:

1. Social withdrawal.
2. Reduced academic performance.
3. Loss of interest in usual activities.
4. Poor concentration.
5. Sleep disturbances.
6. Unusual suspiciousness.
7. Difficulty communicating.
8. Declining personal hygiene.
9. Increased anxiety.
10. Unusual ideas or perceptions.
11. Reduced motivation.
12. Difficulty maintaining relationships.

These symptoms are not specific to schizophrenia.

They may also occur in depression, anxiety disorders, substance-related conditions, developmental disorders, and other medical conditions.

A person with these symptoms should not automatically be labelled as having schizophrenia.

Early professional assessment is important when symptoms are persistent, worsening, or interfering with daily functioning.

10. STAGES AND COURSE OF SCHIZOPHRENIA

The clinical course of schizophrenia differs between individuals.

For educational purposes, it is often described using three broad phases.

10.1 Prodromal phase

The prodromal phase occurs before the development of clear psychotic symptoms.

Features may include:

• Social isolation.
• Reduced concentration.
• Sleep problems.
• Declining academic or occupational performance.
• Suspiciousness.
• Reduced motivation.
• Unusual beliefs.
• Changes in emotional expression.

These changes may develop gradually over weeks, months, or longer periods.

Not everyone who experiences prodromal symptoms develops schizophrenia.

10.2 Acute or active phase

During this phase, prominent psychotic symptoms become apparent.

Features may include:

• Hallucinations.
• Delusions.
• Disorganized speech.
• Disorganized behaviour.
• Severe suspiciousness.
• Agitation.
• Impaired judgment.
• Difficulty distinguishing internal experiences from external reality.

Some patients require urgent psychiatric assessment or hospitalization during this phase.

10.3 Residual or recovery phase

During the residual or recovery phase, acute psychotic symptoms may decrease.

However, the patient may continue to experience:

• Reduced motivation.
• Social withdrawal.
• Cognitive impairment.
• Emotional flattening.
• Reduced occupational functioning.
• Mild or intermittent psychotic symptoms.

Recovery may be gradual and requires continued treatment and rehabilitation.

11. DIAGNOSTIC CRITERIA

The diagnosis of schizophrenia is primarily clinical.

Psychiatrists and other appropriately trained clinicians use established diagnostic criteria, including DSM-5-TR and ICD-11.

Under DSM-5-TR, the diagnostic framework includes the following important requirements.

11.1 Characteristic symptoms

At least two of the following symptoms must be present for a significant portion of time during a one-month period, or less if successfully treated:

1. Delusions.
2. Hallucinations.
3. Disorganized speech.
4. Grossly disorganized or catatonic behaviour.
5. Negative symptoms.

At least one of the symptoms must be delusions, hallucinations, or disorganized speech.

11.2 Functional impairment

The disorder must cause significant impairment in one or more major areas of functioning, such as:

• Work.
• Education.
• Interpersonal relationships.
• Self-care.
• Social functioning.

11.3 Duration

Continuous signs of disturbance must persist for at least six months.

This period includes at least one month of active-phase symptoms, unless symptoms have been successfully treated, and may include prodromal or residual periods.

11.4 Exclusion of other disorders

Schizoaffective disorder and mood disorders with psychotic features must be considered and appropriately excluded.

11.5 Exclusion of substance and medical causes

The symptoms must not be attributable to:

• Substance use.
• Medication effects.
• Another medical condition.

The diagnostic criteria should always be applied by a qualified clinician.

12. CLINICAL HISTORY AND PSYCHIATRIC ASSESSMENT

A detailed clinical history is essential for diagnosing schizophrenia.

The healthcare professional should assess the patient's current symptoms, previous psychiatric history, medical conditions, medication use, substance exposure, family history, and functional abilities.

12.1 Presenting complaints

Ask the patient about:

• Hearing voices.
• Seeing things that others cannot see.
• Suspiciousness.
• Unusual beliefs.
• Sleep disturbances.
• Changes in behaviour.
• Difficulty concentrating.
• Social withdrawal.
• Declining daily functioning.

12.2 History of presenting illness

Important questions include:

• When did the symptoms begin?
• Were the symptoms sudden or gradual?
• Have symptoms become worse over time?
• Are hallucinations present?
• Does the patient experience delusions?
• Are symptoms continuous or episodic?
• Is there a history of previous psychiatric episodes?
• Has the patient received treatment?
• Is there any history of substance use?

12.3 Past psychiatric history

Ask about:

• Previous psychiatric diagnoses.
• Previous hospital admissions.
• Past psychotic episodes.
• Previous suicide attempts.
• Previous medications.
• Response to previous treatment.
• Medication-related adverse effects.

12.4 Family history

Investigate any family history of:

• Schizophrenia.
• Other psychotic disorders.
• Bipolar disorder.
• Depression.
• Suicide.
• Substance use disorders.

12.5 Personal and social history

Assess:

• Educational background.
• Employment.
• Relationships.
• Living conditions.
• Social support.
• Substance use.
• Childhood experiences.
• Recent stressful events.

12.6 Mental status examination

The mental status examination is an essential component of psychiatric assessment.

It includes:

Appearance: Observe clothing, grooming, hygiene, and general physical appearance.

Behaviour: Assess cooperation, eye contact, unusual movements, agitation, and social interaction.

Speech: Evaluate speech rate, volume, rhythm, fluency, and organization.

Mood: Ask the patient how they feel emotionally.

Affect: Observe the range, intensity, and appropriateness of emotional expression.

Thought form: Evaluate the organization and logical flow of thoughts.

Thought content: Assess delusions, suspiciousness, preoccupations, and suicidal or homicidal thoughts.

Perception: Investigate hallucinations and other perceptual abnormalities.

Cognition: Evaluate attention, memory, orientation, and executive functioning.

Insight: Assess the patient's understanding of their illness and need for treatment.

Judgment: Evaluate the patient's ability to make safe and appropriate decisions.

13. INVESTIGATIONS

There is no single laboratory test that confirms schizophrenia.

Investigations are used to identify medical conditions, neurological disorders, substance-related causes, and physical health problems that may resemble or accompany psychosis.

The selection of investigations depends on the patient's history, examination, age, clinical presentation, and associated symptoms.

13.1 Complete blood count

CBC may help identify:

• Anemia.
• Infection.
• Other hematological abnormalities.

It is also important for monitoring certain medications, particularly clozapine, which can cause severe neutropenia.

13.2 Blood glucose and HbA1c

These investigations help assess glucose metabolism.

They are important because some antipsychotic medications can increase the risk of weight gain, insulin resistance, and diabetes.

13.3 Lipid profile

A lipid profile assesses:

• Total cholesterol.
• LDL cholesterol.
• HDL cholesterol.
• Triglycerides.

Monitoring is important because antipsychotic treatment may cause metabolic changes.

13.4 Thyroid function tests

Thyroid disorders can produce psychiatric symptoms.

Testing may be appropriate when the clinical presentation suggests thyroid dysfunction.

13.5 Renal function tests

Blood urea, creatinine, and estimated glomerular filtration rate may be assessed when clinically indicated.

These tests help evaluate general health and guide the use of certain medications.

13.6 Liver function tests

Liver function tests may be performed to identify hepatic disease and assess medication safety.

13.7 Urine toxicology

Drug screening may be appropriate when substance-induced psychosis is suspected.

13.8 Vitamin and nutritional investigations

Depending on the clinical presentation, testing may include:

• Vitamin B12.
• Folate.
• Other nutritional markers.

Deficiencies can sometimes contribute to cognitive or psychiatric symptoms.

13.9 Brain imaging

CT or MRI of the brain is not routinely required for every patient with a typical presentation.

Imaging may be indicated when there are:

• New neurological abnormalities.
• Seizures.
• Head injury.
• Atypical presentation.
• Rapid cognitive deterioration.
• Suspected intracranial disease.

13.10 Electroencephalography

EEG may be useful when seizures or certain neurological conditions are suspected.

13.11 Electrocardiography

ECG may be required before or during treatment with selected antipsychotic medications, particularly when cardiac risk factors or QT prolongation are concerns.

14. DIFFERENTIAL DIAGNOSIS

Several psychiatric, neurological, medical, and substance-related conditions can produce symptoms resembling schizophrenia.

Accurate diagnosis is essential because treatment depends on the underlying condition.

14.1 Bipolar disorder with psychotic features

Bipolar disorder may involve episodes of mania or depression accompanied by psychotic symptoms.

Important differences include the prominent episodic mood disturbance and the relationship between psychosis and mood episodes.

14.2 Major depressive disorder with psychotic features

Severe depression may be accompanied by delusions or hallucinations.

Patients commonly experience persistent sadness, loss of interest, hopelessness, and other depressive symptoms.

14.3 Schizoaffective disorder

Schizoaffective disorder involves symptoms of schizophrenia together with major mood episodes.

The timing and duration of mood and psychotic symptoms help distinguish it from schizophrenia.

14.4 Delusional disorder

Delusional disorder is characterized by persistent delusions without the broader characteristic pattern of schizophrenia.

14.5 Substance-induced psychotic disorder

Certain substances and medications can produce hallucinations, delusions, and disorganized behaviour.

The relationship between substance exposure and symptoms is important.

14.6 Delirium

Delirium is an acute disturbance in attention and awareness.

It commonly develops due to infection, metabolic abnormalities, medication effects, or other medical conditions.

Fluctuating consciousness and impaired attention are important clues.

Delirium requires prompt medical assessment.

14.7 Neurological disorders

Some neurological conditions can produce psychotic symptoms.

Examples include:

• Epilepsy.
• Brain tumours.
• Encephalitis.
• Neurodegenerative disorders.
• Certain autoimmune neurological conditions.

15. MANAGEMENT OF SCHIZOPHRENIA

Management requires a comprehensive and individualized approach.

The main goals are to:

1. Reduce hallucinations and delusions.
2. Control acute psychotic symptoms.
3. Prevent relapse.
4. Improve cognitive and social functioning.
5. Reduce the risk of self-harm.
6. Improve medication adherence.
7. Support independent living.
8. Improve quality of life.
9. Address physical health problems.
10. Promote long-term recovery.

Treatment usually combines pharmacological and psychosocial interventions.

16. PHARMACOLOGICAL TREATMENT

Antipsychotic medications are the main pharmacological treatment for schizophrenia.

They help reduce psychotic symptoms by modifying neurotransmitter activity, particularly dopamine signalling.

The choice of medication depends on:

• Symptom severity.
• Previous response.
• Adverse effects.
• Physical health.
• Patient preference.
• Pregnancy considerations.
• Other medications.
• Cost and availability.

Medication should be prescribed and monitored by an appropriately qualified clinician.

16.1 First-generation antipsychotics

First-generation antipsychotics are also known as typical antipsychotics.

They primarily act by blocking dopamine D2 receptors.

Examples include:

Haloperidol: Commonly used for psychotic symptoms and certain acute psychiatric presentations.

Chlorpromazine: An older antipsychotic medication that may cause sedation, hypotension, and anticholinergic effects.

Fluphenazine: A typical antipsychotic available in oral and long-acting injectable formulations.

Adverse effects

Important adverse effects include:

• Extrapyramidal symptoms.
• Acute dystonia.
• Parkinsonism.
• Akathisia.
• Tardive dyskinesia.
• Hyperprolactinemia.
• Sedation.
• Orthostatic hypotension.

16.2 Second-generation antipsychotics

Second-generation antipsychotics are also known as atypical antipsychotics.

They generally act through combinations of dopamine and serotonin receptor effects.

Examples include:

Risperidone: Effective for positive symptoms but may increase prolactin and cause extrapyramidal effects, particularly at higher doses.

Olanzapine: Can improve psychotic symptoms but is associated with significant weight gain and metabolic adverse effects.

Quetiapine: May cause sedation, dizziness, and metabolic effects.

Aripiprazole: A dopamine partial agonist that may cause akathisia and restlessness.

Amisulpride: A dopamine receptor antagonist used in some countries for schizophrenia.

Paliperidone: A medication related to risperidone that is available in oral and long-acting injectable forms.

Advantages

Second-generation medications may have a lower risk of some movement-related adverse effects compared with certain first-generation medications.

However, their metabolic and other adverse effects differ considerably.

Adverse effects

Possible adverse effects include:

• Weight gain.
• Increased blood glucose.
• Increased cholesterol.
• Sedation.
• Orthostatic hypotension.
• Sexual dysfunction.
• Increased prolactin with certain agents.
• Movement disorders.

16.3 Clozapine

Clozapine is an important antipsychotic medication used in treatment-resistant schizophrenia.

It is generally considered when adequate trials of other appropriate antipsychotic medications have not produced sufficient improvement.

Clozapine may be particularly beneficial for patients with persistent symptoms despite standard treatment.

Important adverse effects

• Severe neutropenia or agranulocytosis.
• Myocarditis.
• Cardiomyopathy.
• Seizures.
• Severe constipation and gastrointestinal hypomotility.
• Weight gain.
• Metabolic abnormalities.
• Sedation.
• Excessive salivation.

Monitoring

Patients receiving clozapine require regular blood monitoring according to the applicable local prescribing and monitoring requirements.

Clinicians must also assess cardiovascular symptoms, bowel function, metabolic health, and other possible adverse effects.

Fever, chest pain, breathing difficulties, or severe constipation require prompt medical evaluation.

16.4 Long-acting injectable antipsychotics

Long-acting injectable antipsychotics are formulations administered at intervals determined by the specific medication.

Examples include:

• Long-acting risperidone.
• Paliperidone palmitate.
• Aripiprazole long-acting formulations.
• Fluphenazine decanoate.

Benefits

They may be useful for patients who:

• Prefer injectable treatment.
• Have difficulty taking daily medication.
• Experience repeated relapses associated with missed doses.
• Require a treatment plan that supports continuity of care.

The choice should involve shared decision-making between the patient and healthcare professional.

17. PSYCHOLOGICAL TREATMENT

Medication alone may not address all the difficulties associated with schizophrenia.

Psychological therapies are important components of comprehensive treatment.

17.1 Cognitive behavioural therapy for psychosis

Cognitive behavioural therapy for psychosis, commonly called CBTp, is a structured psychological intervention.

It helps patients understand and respond to distressing experiences.

The main objectives include:

• Reducing distress associated with hallucinations.
• Examining beliefs and interpretations.
• Developing coping strategies.
• Improving emotional regulation.
• Managing anxiety.
• Supporting daily functioning.
• Improving confidence and self-management.

CBTp does not require the patient to accept that their experiences are imaginary.

Instead, the therapist works collaboratively with the patient to explore alternative explanations and reduce distress.

17.2 Family intervention

Family intervention is an important component of schizophrenia management.

Family members often provide long-term practical and emotional support.

Family-based interventions may include:

• Education about schizophrenia.
• Recognition of early warning signs.
• Communication skills.
• Problem-solving techniques.
• Relapse prevention.
• Stress management.
• Medication education.

The purpose is to improve understanding and reduce family stress.

17.3 Psychoeducation

Psychoeducation involves providing accurate information about the disorder and its treatment.

Topics include:

• Nature of schizophrenia.
• Symptoms.
• Causes and risk factors.
• Medication benefits.
• Adverse effects.
• Relapse prevention.
• Importance of follow-up.
• Lifestyle management.

Psychoeducation helps patients and families participate more effectively in treatment decisions.

17.4 Social skills training

Schizophrenia may interfere with communication and social interaction.

Social skills training helps patients develop abilities such as:

• Starting conversations.
• Maintaining relationships.
• Expressing feelings.
• Understanding social situations.
• Solving interpersonal problems.
• Managing conflicts.

17.5 Cognitive remediation

Cognitive remediation aims to improve cognitive functioning through structured exercises and strategies.

It may target:

• Attention.
• Memory.
• Processing speed.
• Planning.
• Problem-solving.
• Executive functioning.

These interventions may improve the patient's ability to participate in daily activities.

18. PSYCHOSOCIAL REHABILITATION

Psychosocial rehabilitation aims to improve independence and social participation.

It recognizes that recovery involves more than reducing hallucinations and delusions.

Important components include:

18.1 Occupational rehabilitation

Occupational rehabilitation helps patients develop skills required for daily living and employment.

Examples include:

• Cooking.
• Cleaning.
• Personal hygiene.
• Time management.
• Financial management.
• Household responsibilities.
• Work-related skills.

18.2 Vocational rehabilitation

Vocational rehabilitation supports individuals who want to return to work or develop employment skills.

It may involve:

• Career counselling.
• Job training.
• Supported employment.
• Workplace adjustments.
• Employment assistance.

18.3 Educational support

Some patients experience academic difficulties due to cognitive symptoms or interruptions in education.

Educational support may include:

• Additional learning time.
• Flexible study arrangements.
• Counselling.
• Academic assistance.
• Structured learning programmes.

18.4 Community-based care

Community mental health services can help patients remain connected with their families and communities.

These services may provide:

• Regular follow-up.
• Medication support.
• Rehabilitation.
• Crisis intervention.
• Social support.
• Housing assistance.

19. MANAGEMENT OF ACUTE PSYCHOSIS

Acute psychosis requires prompt and careful clinical assessment.

The immediate priorities are patient safety, evaluation of possible medical causes, reduction of distress, and initiation of appropriate treatment.

19.1 Initial assessment

Assess:

• Airway, breathing, and circulation when indicated.
• Level of consciousness.
• Vital signs.
• Hydration.
• Nutritional status.
• Possible intoxication.
• Risk of self-harm.
• Risk of harm to others.
• Ability to care for basic needs.

19.2 Therapeutic communication

Healthcare professionals should:

• Speak calmly.
• Use short and clear sentences.
• Avoid shouting.
• Maintain a respectful distance.
• Avoid unnecessary confrontation.
• Listen carefully.
• Provide reassurance without making unrealistic promises.

19.3 Risk assessment

Assess for:

• Suicidal thoughts.
• Previous suicide attempts.
• Command hallucinations.
• Severe agitation.
• Threats toward others.
• Self-neglect.
• Inability to maintain basic safety.
• Access to potentially harmful means.

19.4 Medication

Antipsychotic medication may be initiated or adjusted according to the clinical condition.

The clinician should consider previous treatment, medication history, medical conditions, adverse effects, and patient preference.

Emergency medication and restrictive interventions should only be used when clinically justified, proportionate, and consistent with applicable laws and guidelines.

19.5 Hospitalization

Hospital admission may be necessary when:

• There is an immediate risk of suicide.
• The patient presents a serious risk of harm.
• Severe psychosis prevents basic self-care.
• The patient has serious medical complications.
• Intensive observation or treatment is required.

The least restrictive appropriate care setting should be used.

20. NURSING MANAGEMENT OF SCHIZOPHRENIA

Nurses play a major role in the assessment, treatment, monitoring, rehabilitation, and long-term support of patients with schizophrenia.

Nursing care should be individualized according to the patient's symptoms, level of functioning, physical health, and safety needs.

20.1 Nursing assessment

The nurse should assess:

Physical health:

• Blood pressure.
• Pulse.
• Temperature.
• Respiratory rate.
• Weight.
• Nutritional status.
• Hydration.
• Sleep pattern.
• Personal hygiene.

Psychological health:

• Hallucinations.
• Delusions.
• Mood.
• Anxiety.
• Behaviour.
• Thought processes.
• Insight.
• Judgment.

Social functioning:

• Family relationships.
• Communication.
• Employment.
• Education.
• Social support.
• Daily living activities.

Safety:

• Suicidal thoughts.
• Self-harm.
• Aggressive behaviour.
• Severe agitation.
• Neglect of basic needs.

20.2 Nursing diagnosis

Possible nursing diagnoses include:

1. Disturbed sensory perception related to altered perception.
2. Disturbed thought processes related to psychotic symptoms.
3. Impaired verbal communication related to disorganized thinking.
4. Social isolation related to reduced social interaction.
5. Self-care deficit related to reduced motivation.
6. Ineffective coping related to psychological distress.
7. Disturbed sleep pattern related to psychiatric symptoms.
8. Risk for self-directed violence.
9. Imbalanced nutrition when nutritional intake is inadequate.
10. Impaired social interaction related to difficulties in communication.

These are examples and should be selected according to the individual patient's assessment.

20.3 Nursing interventions for hallucinations

The nurse should:

• Assess the type and content of hallucinations.
• Determine how frequently they occur.
• Ask whether the voices give commands.
• Assess whether the patient feels threatened.
• Avoid arguing about the hallucination.
• Acknowledge the patient's emotional distress.
• Gently explain what the nurse can and cannot perceive.
• Encourage the patient to participate in reality-based activities.
• Reduce excessive environmental stimulation when necessary.
• Report dangerous command hallucinations immediately.

Example of therapeutic communication:

"I understand that hearing these voices is frightening. I cannot hear them, but I am here to help you feel safe."

20.4 Nursing interventions for delusions

The nurse should:

• Listen without judgment.
• Avoid reinforcing false beliefs.
• Avoid aggressive confrontation.
• Focus on the patient's feelings.
• Provide simple factual information.
• Maintain a calm environment.
• Encourage participation in ordinary activities.
• Assess whether delusions are associated with dangerous behaviour.

For example, if a patient believes that someone is trying to harm them, the nurse can acknowledge their fear without agreeing that the threat is real.

20.5 Nursing interventions for social withdrawal

The nurse should:

• Encourage gradual social interaction.
• Establish a trusting relationship.
• Begin with simple one-to-one conversations.
• Offer structured group activities.
• Avoid forcing participation.
• Recognize small improvements.
• Encourage family involvement when appropriate.

20.6 Nursing interventions for self-care deficits

The nurse should assess the patient's ability to perform:

• Bathing.
• Dressing.
• Grooming.
• Oral hygiene.
• Eating.
• Toileting.

Assistance should be provided according to the patient's needs.

The aim is to encourage independence rather than creating unnecessary dependence.

20.7 Medication administration

Nurses should:

• Administer medication as prescribed.
• Explain the purpose of treatment.
• Monitor therapeutic response.
• Observe adverse effects.
• Encourage the patient to report unusual symptoms.
• Document medication administration.
• Monitor adherence.
• Educate patients about the importance of follow-up.

20.8 Nursing care during acute agitation

The nurse should:

• Maintain a safe environment.
• Use a calm and non-threatening approach.
• Reduce unnecessary noise and stimulation.
• Avoid sudden movements.
• Provide clear instructions.
• Allow sufficient personal space.
• Seek assistance when risk increases.
• Follow the institution's emergency procedures.

20.9 Health education

The nurse should educate patients and caregivers about:

• Schizophrenia.
• Medication adherence.
• Recognition of relapse.
• Healthy sleep habits.
• Avoiding recreational drugs.
• Avoiding harmful substance use.
• Balanced nutrition.
• Regular exercise.
• Follow-up appointments.
• Physical health monitoring.

21. COMPLICATIONS OF SCHIZOPHRENIA

Schizophrenia may lead to several psychiatric, physical, social, and occupational complications.

Some complications result from the disorder itself, while others may be associated with medication adverse effects, substance use, and inadequate access to healthcare.

21.1 Suicide and self-harm

People with schizophrenia have an increased risk of suicide compared with the general population.

Risk may be increased by:

• Depression.
• Hopelessness.
• Severe psychotic symptoms.
• Command hallucinations.
• Previous suicide attempts.
• Substance misuse.
• Social isolation.
• Recent discharge from hospital.

Suicide risk must be assessed regularly.

Any expression of suicidal intent or immediate danger requires urgent professional intervention.

21.2 Social isolation

Patients may gradually withdraw from family members, friends, and community activities.

This can increase loneliness and reduce social support.

21.3 Poor occupational functioning

Cognitive difficulties and persistent symptoms may interfere with:

• Education.
• Employment.
• Financial independence.
• Professional development.

21.4 Substance use disorders

Some individuals with schizophrenia also experience alcohol or drug use disorders.

Substance use can worsen symptoms, increase relapse risk, and complicate treatment.

21.5 Metabolic complications

Certain antipsychotic medications can contribute to:

• Obesity.
• Diabetes mellitus.
• Dyslipidemia.
• Metabolic syndrome.

Regular physical health monitoring is important.

21.6 Cardiovascular disease

People with schizophrenia experience increased cardiovascular risk.

Contributing factors may include:

• Smoking.
• Physical inactivity.
• Poor diet.
• Metabolic abnormalities.
• Limited access to medical care.

21.7 Extrapyramidal symptoms

Some antipsychotics can cause movement-related adverse effects.

These include:

• Acute dystonia.
• Parkinsonism.
• Akathisia.
• Tardive dyskinesia.

21.8 Neuroleptic malignant syndrome

Neuroleptic malignant syndrome is a rare but potentially life-threatening adverse reaction associated with antipsychotic medications.

Features include:

• High fever.
• Severe muscle rigidity.
• Altered mental status.
• Autonomic instability.
• Elevated creatine kinase.

It requires immediate medical attention and emergency management.

21.9 Tardive dyskinesia

Tardive dyskinesia is a movement disorder that may develop after prolonged exposure to dopamine receptor-blocking medications.

Common features include:

• Repetitive lip movements.
• Tongue movements.
• Facial grimacing.
• Chewing movements.
• Involuntary movements of the limbs.

Early recognition and medication review are important.

21.10 Reduced life expectancy

People with schizophrenia experience higher premature mortality than the general population.

Contributing factors include cardiovascular disease, metabolic disorders, infections, suicide, smoking, and inadequate treatment of physical illnesses.

22. RELAPSE AND ITS PREVENTION

Relapse refers to the return or significant worsening of symptoms after a period of improvement or remission.

Relapse can interfere with education, employment, relationships, and independent functioning.

22.1 Causes of relapse

Common contributing factors include:

• Stopping medication without medical advice.
• Irregular medication use.
• Substance misuse.
• Severe stress.
• Sleep deprivation.
• Poor family support.
• Untreated physical illness.
• Inadequate follow-up.
• Changes in the treatment plan.

22.2 Early warning signs of relapse

Warning signs may include:

1. Sleep disturbances.
2. Increased suspiciousness.
3. Social withdrawal.
4. Declining self-care.
5. Reduced concentration.
6. Increasing anxiety.
7. Unusual beliefs.
8. Increased irritability.
9. Return of hallucinations.
10. Declining daily functioning.

22.3 Prevention strategies

Relapse prevention includes:

• Continuing prescribed medication.
• Attending regular psychiatric appointments.
• Recognizing early warning signs.
• Avoiding recreational drugs.
• Managing stress.
• Maintaining a regular sleep routine.
• Participating in psychological treatment.
• Maintaining family and social support.
• Seeking early help when symptoms worsen.

Medication should not be stopped or changed without professional guidance.

23. LIFESTYLE MODIFICATIONS

Healthy lifestyle habits are important for people living with schizophrenia.

They support general health, improve daily functioning, and may reduce some physical health risks.

23.1 Healthy diet

A balanced diet should include:

• Fruits.
• Vegetables.
• Whole grains.
• Protein-rich foods.
• Healthy fats.
• Adequate water.

Patients taking antipsychotic medication should receive appropriate advice about weight management and metabolic health.

23.2 Regular exercise

Physical activity can improve cardiovascular health, metabolic functioning, mood, and general well-being.

Examples include:

• Walking.
• Cycling.
• Swimming.
• Light resistance exercises.
• Stretching.

Exercise should be adapted to the individual's physical condition.

23.3 Adequate sleep

A regular sleep schedule is important.

Patients should be encouraged to:

• Maintain consistent sleeping hours.
• Reduce excessive nighttime screen use.
• Avoid excessive caffeine.
• Create a comfortable sleeping environment.
• Seek help for persistent insomnia.

23.4 Avoidance of harmful substances

Patients should be advised to avoid recreational drugs, particularly cannabis and stimulants.

Smoking cessation and reduction of harmful alcohol use should also be supported.

23.5 Social engagement

Maintaining supportive relationships can help reduce isolation.

Patients should be encouraged to participate in meaningful activities according to their abilities and preferences.

24. PROGNOSIS

The prognosis of schizophrenia varies considerably.

Some individuals experience substantial improvement and maintain independent lives, while others require continuing support.

Factors associated with a more favourable outcome may include:

• Early recognition.
• Early treatment.
• Good treatment adherence.
• Strong social support.
• Better premorbid functioning.
• Limited substance use.
• Good access to mental healthcare.
• Participation in rehabilitation.

Factors associated with poorer outcomes may include:

• Long delays before treatment.
• Persistent untreated psychosis.
• Severe negative symptoms.
• Significant cognitive impairment.
• Repeated relapses.
• Substance use disorders.
• Limited social support.
• Poor access to healthcare.

Recovery does not necessarily mean that every symptom disappears permanently.

For some individuals, recovery means achieving better symptom control, improved relationships, greater independence, and meaningful participation in everyday life.

25. PREVENTION

There is currently no guaranteed method of preventing schizophrenia.

However, early identification and appropriate intervention may reduce complications and improve long-term outcomes.

Important preventive approaches include:

25.1 Early recognition

Persistent changes in thinking, behaviour, social functioning, or perception should receive appropriate assessment.

25.2 Early treatment

Prompt assessment and treatment of a first psychotic episode may improve outcomes.

25.3 Substance avoidance

Avoiding cannabis and other psychoactive substances, particularly during adolescence and early adulthood, may reduce avoidable psychosis-related risks.

25.4 Family education

Families should learn to recognize early warning signs and understand how to support treatment.

25.5 Community mental health services

Accessible mental health services can reduce delays in diagnosis and treatment.

26. SCHIZOPHRENIA IN CHILDREN AND ADOLESCENTS

Schizophrenia beginning during childhood is rare.

When it occurs, it may cause serious disturbances in development, learning, behaviour, and social functioning.

Possible symptoms include:

• Hallucinations.
• Delusions.
• Disorganized speech.
• Social withdrawal.
• Unusual behaviour.
• Declining academic performance.
• Cognitive difficulties.

The diagnosis is challenging because several developmental, neurological, and psychiatric conditions can produce similar symptoms.

A detailed specialist assessment is essential.

Treatment may include carefully selected medication, psychological interventions, family support, educational assistance, and long-term monitoring.